|

Candesartan Clinical Trials

2 actively recruiting trials

Also known as: Cansartan

Pipeline

Phase 3: 2

Top Sponsors

  • Sherief Abd-Elsalam1
  • Cristina Avendaño Solá1

Indications

  • Liver Fibroses1
  • Cardiomyopathy, Dilated1
  • Liver Disease1
  • Heart Disease1

Other2 trials

Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)
Phase 3
Effect of Some Drugs on Liver Fibrosis
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.